Methods for Elucidation of DNA-Anticancer Drug Interactions and their Applications in the Development of New Drugs

E-ISSN： 1873-4286|22|44|6596-6611

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.22, Iss.44, 2017-01, pp. : 6596-6611

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Effects of anticancer drugs on transcription factor–DNA interactions

By Gniazdowski Marek Denny William A Nelson Stephanie M Czyz Malgorzata

Expert Opinion on Therapeutic Targets, Vol. 9, Iss. 3, 2005-06 ,pp. : 471-489

Informa Healthcare

Access to resources Recommend Favorite

Development of distamycin-related DNA binding anticancer drugs

By Marchini Sergio Broggini Massimo Sessa Cristiana D’Incalci Maurizio

Expert Opinion on Investigational Drugs, Vol. 10, Iss. 9, 2001-09 ,pp. : 1703-1714

Informa Healthcare

Access to resources Recommend Favorite

Geminin as A Molecular Target for the Development of New Anticancer Drugs

Mini Reviews in Medicinal Chemistry, Vol. 6, Iss. 4, 2006-04 ,pp. : 461-462

Bentham Science Publishers

Access to resources Recommend Favorite

New methods to assist anticancer drug delivery emerging

Inpharma, Vol. 1, Iss. 1649, 2008-01 ,pp. : 9-9

Adis International

Access to resources Recommend Favorite

A Quantitative Framework and Strategies for Management and Evaluation of Metabolic Drug-Drug Interactions in Oncology Drug Development: New Molecular Entities as Object Drugs

By Venkatakrishnan Karthik

Clinical Pharmacokinetics, Vol. 49, Iss. 11, 2010-11 ,pp. : 703-727

Adis International

Access to resources Recommend Favorite